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Abstract Lung metastasis remains the major cause of cancer
related mortality in patients with breast, gastrointestinal,
sarcoma, melanoma and kidney cancer. Here we characterize
the expression of selectins during metastatic lung colonization
and analyzed their function in the formation of pulmonary
metastasis. E-selectin, together with VCAM-1, were detected
6 h after the microvascular arrest of tumor cells indicating an
inflammatory activation of the local endothelial cells. No E-
selectin expression was detected in pre-metastatic lungs of
mice carrying primary tumors. P- and L-selectin were present
during initiating steps of lung colonization and correlated with
the recruitment of platelets and leukocytes to metastatic tumor
cells. Experimental metastasis was significantly reduced in the
absence of P- or L-selectin while no attenuation of metastasis
was observed in E-selectin-deficient mice. Collectively,
selectins are upregulated within the metastatic microenviron-
ment of tumor cells and the formation of a permissive
metastatic microenvironment is facilitated by P- and L-
selectin mediated interactions between tumor cells and blood
components. E-selectin does not affect metastatic initiation in
the lung tissue and its expression rather indicates a local
activation of lung microvascular endothelial cells.
Keywords Endothelium . Selectins . Metastasis .
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Introduction
The formation of metastatic lesions remains the major
cause for cancer-related morbidity and mortality. Metas-
tasis to vital organs such as liver or lungs occurs
through hematogenous dissemination that encompasses
multiple steps including intravasation, transportation and
survival in circulation, extravasation and colonization of
distant tissues [1, 2]. In general, metastasis is an
inefficient process, whereas tissue colonization is consid-
ered to be the rate-limiting step [3, 4]. Tumor cells with a
genetic make-up that allows them to adapt the new
environment will successfully colonize distant organs [1,
5, 6]. Metastatic tumor cells interact with the local
microenvironment, thereby forming a metastatic niche
permissive for the establishment of metastatic lesions [6,
7]. Depending on the target tissue, tumor cells exhibit a
distinct set of properties required for metastasis [1, 6, 8].
Mammary carcinoma cells adopt and activate different
molecular pathways depending on the colonized tissue,
e.g. bone or lungs [9–11]. While the discontinuous
endothelial lining of the hepatic or bone vasculature
allows tumor cells to exit from the circulation rather
rapidly, anatomy of the lung with a tight capillary bed
seems to be an especially hostile environment for
metastasizing tumor cells [12]. During hematogenous
phase, tumor cell interactions with blood elements (cells
and soluble factors) and the pulmonary microvascular
endothelium are critical for metastasis [6, 13–16].
Specifically, the interaction of platelets with tumor cells
enhances the tumor cell survival within the metastatic,
pulmonary microenvironment [17–19]. The recruitment
of leukocytes, mainly myeloid cells, to metastasizing
tumor cells was shown to promote lung colonization in
mice [20–23].
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Metastasis-promoting interactions of tumor cells with
platelets and leukocytes were shown to be initiated by
P- and L-selectins [19, 21, 23]. The absence of P- and/or
L-selectin as well as the blockage of any of these selectins
led to a significant attenuation of metastasis [19, 21].
Furthermore, the effect of heparin on metastasis is to a
large extent ascribed to the inhibition of P- and L-selectin
mediated interactions [24–26]. E-selectin is present only
on activated endothelial cells from various vascular beds
[27]. Several studies demonstrated that the hepatic
sinusoidal endothelium is activated during the initial
phase of metastatic liver colonization [28–30]. This
endothelial activation was associated with an upregulation
of cell adhesion molecules including E-selectin and
VCAM-1, that was similar to a local inflammatory
reaction [28]. Upregulation of E-selectin expression in
the liver was associated with enhanced formation of
metastasis [31, 32]. In this work we aimed to characterize
the expression and the function of all three selectins (E-,
P-, and L-) during lung colonization in an experimental
metastasis model.
Material and Methods
Cell Culture
MC-38 and MC-38GFP murine colon adenocarcinoma cells
were grown as described previously [19]. Human colon
carcinoma cells, LS180 tumor cells were grown in DMEM
medium containing 10% FCS. Hybridomas producing L-
selectin antibody (MEL-14 clone from ATCC) were grown
and the antibody purified as described previously [21].
Experimental Metastasis
LS180 tumor cells (350,000 cells, passage 2–4) were
injected into the lateral tail vein of Rag2 deficient
(Rag2-/-) or selectin deficient mice in a Rag2 back-
ground (Esel-/-/Rag2-/-; Psel-/-/Rag2-/-; or Lsel -/-/
Rag2-/-). Mice (groups of 5–8) were euthanized 6 weeks
later, and lungs were dissected. Isolated genomic DNA
was analyzed for human ALU sequences by densitom-
etry as previously described [24].
C57BL6 mice (Jackson Lab) were intravenously injected
with 300,000 of MC-38GFP cells (passage 2–4). In some
experiments, MC-38GFP cells were injected intravenously
into C57BL6 mice bearing subcutaneous MC-38 tumors.
Subcutaneous injection of 2×106 of MC-38 cells in the
right flank was performed 2 weeks prior to intravenous
injection of MC-38GFP cells. Mice were euthanized at
indicated time points, and PFA fixed lungs dissected for
histological studies.
Spontaneous Metastasis
3LL tumor cells (1×106 cells) constitutively expressing
firefly luciferase and GFP were subcutaneously injected in
the right flank of C57BlJ6 mice. Mice (groups of 6–7) were
euthanized at different time points after tumor cell
inoculation. Lung metastasis was assessed by histology
and detection of GFP positive cells.
Detection of Selectins and VCAM-1
Lungs isolated from mice injected with MC-38GFP cells
were frozen in O.C.T. (Sakura) and 8–10 μm lung sections
stained with monoclonal antibodies against murine E-
selectin, P-selectin, VCAM-1 (BD Biosciences) or L-
selectin, MEL-14. Specific staining was detected by goat-
anti-rat-Alexa568 antibody (Invitrogen). Images were
obtained with a confocal microscope (SP5, Leica) using
a 63x objective (NA 1.4, oil immersion) and subsequently
analyzed with Imaris Software (Bitplane). Image stacks of
42–43 images with approximately 6 µm in the z-axis were
acquired with similar settings between different condi-
tions. Positive voxels for respective antibodies were quan-
tified in a microenvironment centered on a metastasizing
MC-38GFP tumor cell within a volume of 15,000 µm3 by
cropping image-stacks to 50×50 µm in x- and y-axis with
Imaris software (Bitplane). For the semiquantitative analysis
we analyzed 10–15 images per each staining usually
obtained from at least two different mice.
Statistical Analysis
Statistical significance was calculated with the Student’s t
test or by analysis of variance (ANOVA) where appropriate.
Results
E-selectin in the Pulmonary Metastatic Microenvironment
E-selectin is expressed on activated endothelial cells and was
shown to be upregulated during the metastatic colonization of
the liver [33]. To study the E-selectin expression during lung
colonization, we used intravenous injection of MC-38GFP
tumor cells that metastasize to the lungs. Mice were
terminated at different time points after the tumor cell
injection and lungs were evaluated for the presence of E-
selectin. A strong expression of E-selectin was observed in
the vicinity of metastatic tumor cells 6 and 12 h after the
tumor cell injection, while the expression diminished after
48 h (Fig. 1). In the lungs of mice without tumor cell
injection no E-selectin expression was detected (data not
shown). The specific activation of endothelium in the
98 H. Läubli, L. Borsig
vicinity of tumor cells was further confirmed by detection of
VCAM-1 expression (Fig. 2). Similar to the E-selectin
upregulation, VCAM-1 expression was increased between
6 and 24 h after the injection of MC-38GFP cells (Fig. 2).
These findings indicate that tumor cell interactions with the
microenvironment induce an inflammatory-like activation of
endothelial cells during the initial steps of lung colonization.
E-selectin Expression in the Pre-Metastatic Lung
Several recent studies described the formation of a pre-
metastatic niche in distant organs that preceded the dissem-
ination of tumor cells [34–36]. Different soluble factors
secreted by the primary tumor, including VEGF-A, LOX and
TGFβ, were identified to be responsible for generation of a
pre-metastatic niche that is associated with the upregulation
of molecules such as MMP9 and fibronectin [34, 36, 37]. To
test whether lung endothelial activation can be observed in a
tumor-bearing mouse, we analyzed lungs for E-selectin
expression from mice with 2 weeks old subcutaneous MC-
38 tumors. No spontaneous metastasis to the lungs has been
observed. In addition, no significant alteration in E-selectin
expression was observed in mice with subcutaneous tumors
(mean E-selectin voxels count=8,427 in untreated C57BL6
mice vs. 6,029 in mice with subcutaneously grown MC-38
tumor, p=0.24 by Student t-test, Fig. 3a). To determine
whether any activation of pulmonary vasculature is affected
by the presence of a primary tumor, we injected MC-38GFP
cells into the lateral tail vein of mice bearing established
subcutaneous MC-38 tumors. E-selectin expression during
the first 24 h after tumor cell injection has showed a similar
time course as observed before in mice without subcutane-
ous tumors (Fig. 3b).
To analyze the contribution of E-selectin to metastasis we
used a spontaneous metastasis model using mouse Lewis
Lung carcinoma cells (3LL), which upon subcutaneous
injection metastasize to the lungs. During the first 17 days
after tumor cell inoculation, there was no evidence of lung
metastasis. At this time point E-selectin expression in the
pulmonary tissue was not significantly upregulated (mean E-
selectin voxels=8,427 in lungs of mice without tumor cell
inoculation vs. 5,090 in lungs of mice with subcutaneous 3LL
tumors 17 days after inoculation, p=0.44 by ANOVA).
Twenty four days after the subcutaneous injection of 3LL
cells, nearly all examined lungs showed metastatic nodules
(Supplementary Figure 1). Increased expression of E-selectin
was detected only in the proximity of already established
metastatic foci (mean E-selectin voxels=35 413, p=0.01 by
ANOVA, Fig. 3c). Collectively, these observations indicate
that E-selectin is detected only in the proximity of
disseminated tumor cells in lungs and is not upregulated by
distant mediators in an endocrine fashion.
Detection of P- and L-selectin in the Vicinity of Metastatic
Tumor Cells
Experimental metastasis of several tumor cells was shown
to be dependent on P- and L-selectin-mediated interactions
Fig. 1 E-selectin expression
during metastatic colonization
of the lungs. C57Bl6 mice were
intravenously injected with MC-
38GFP cells and lungs analyzed
at indicated time points. a Rep-
resentative images of E-selectin
expression (red) in the pulmo-
nary microenvironment of
metastasizing tumor cells
(green). Nuclei were stained
with DAPI (blue). Bar=20 μm.
b Semiquantitative analysis of
E-selectin expression around
metastatic MC-38GFP cells
during early pulmonary
colonization was performed by
Imaris software
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within the vasculature [16, 19, 21, 24, 38, 39]. P-selectin on
activated platelets facilitates the binding to mucins on
tumor cell surfaces, thereby protecting tumor cells from
immune-mediated lysis [17, 18, 24]. L-selectin deficiency
has led to reduced metastasis that was associated with a
decreased recruitment of leukocytes to metastatic tumor
cells in the lung tissues [21]. Recently, P- and L-selectin
mediated interactions were shown to support metastasis by
creation of a permissive metastatic microenvironment [23].
To determine the time dependence of P- and L-selectin
appearance in the metastatic microenvironment, lung
sections of mice injected with MC-38GFP cells were
analyzed at different time points. Early tumor cell detection
in the pulmonary vasculature was associated with an
accumulation of P-selectin signal in a form of an anuclear
cloak around tumor cells as early as 30 min post-tumor cell
injection (Fig. 4a). P-selectin staining in the vicinity of
intravascular tumor cells was rapidly reduced within 3–6 h
post-tumor cell injection and was eliminated within 24 h
(Fig. 4b). The observed time course was similar to the
accumulation of platelets around MC-38GFP cells during
lung colonization [21]. This finding suggests that the
detected P-selectin was mainly derived from activated
platelets. However, some intracellular staining of P-
selectin in lungs of mice without tumor cell injection was
observed, that corresponded to endothelial P-selectin (data
not shown).
L-selectin positive cells were counted in the vicinity
of metastatic tumor cells (Fig. 5a,b). An enhanced
recruitment of L-selectin positive cells was detected
between 12 and 24 h after tumor cell injection. Likewise,
the quantification of L-selectin positive signal in the
vicinity of MC-38GFP positive cells showed an increased
detection between 12 and 24 h after tumor cell arrest in the
pulmonary microvasculature (Fig. 5c). Since L-selectin
expression is restricted to leukocytes [27], the observed
association of L-selectin positive cells corresponded to a
recruitment of leukocytes. This is in agreement with the
previously observed accumulation of Mac-1 positive
leukocytes during early lung colonization [21]. Taken
together, P-selectin is detected in the pulmonary metastatic
microenvironment of tumor cells as early as 30 min after
their intravascular injection, while the presence of L-
selectin-positive leukocytes is observed mainly at time-
points beyond 12 h.
Effect of E-selectin on Pulmonary Metastasis
The finding that E-selectin expression is upregulated in the
metastatic microenvironment of pulmonary arrested tumor
cells regardless of an existing primary tumor (Fig. 3)
suggested that E-selectin expression is rather a consequence
of local endothelial activation. Therefore we aimed to
analyze the contribution of E-selectin to metastasis in E-
Fig. 2 VCAM-1 expression
during metastatic colonization
of the lungs. C57Bl6 mice were
intravenously injected with MC-
38GFP cells and lungs analyzed
at indicated time points. a Rep-
resentative images of VCAM-1
expression (red) in the meta-
static microenvironment of
tumor cells (green). Nuclei were
stained with DAPI (blue).
Bar=20 μm. b Semiquantitative
analysis of VCAM-1 expression
around metastatic MC-38GFP
cells during early pulmonary
colonization was performed
by Imaris software
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selectin deficient mice. Since both murine MC-38GFP [19]
and 3LL cells (manuscript in preparation) do not express E-
selectin ligands, we used human LS180 tumor cells that
carry selectin ligands for all three selectins [40]. LS180
cells were injected in a Rag2-/- immune-deficient mice
either with or without E-selectin Esel-/-/Rag2-/- and
terminated after 6 weeks. No significant reduction of
metastasis was detected in E-selectin deficient mice when
compared to control Rag2-/- mice (Fig. 6). By contrast, a
strong attenuation of metastasis was observed in mice
deficient in L- or P-selectin as described previously [19,
24]. These results indicate that endothelial E-selectin
expression in the pulmonary tissue has a minor or
redundant function during metastasis.
Discussion
In this work we compared the relative contributions of E-,
P- and L-selectin to lung metastasis. E-selectin was
upregulated in the metastatic microenvironment several
hours after the microvascular arrest of tumor cells. The
detected E-selectin expression was concomitant to the
upregulation of VCAM-1, indicating an inflammatory
activation of the metastatic microenvironment. This notion
is further supported by the observed recruitment of
inflammatory cells (monocytes, neutrophil-granulocytes)
to metastatic tumor cells [21–23]. A similar inflammatory
activation was also observed in the sinusoidal endothelial
cells of the liver during the metastatic colonization that led
Fig. 3 E-selectin expression in pre-metastatic lungs. a Mice
subcutaneously injected with MC-38 tumor cells were analyzed for
the expression of E-selectin in the lungs after 14 days (MC-38
tumor) and compared to lungs of mice without tumor (no tumor).
Mice bearing subcutaneous MC-38 tumors for 14 days were injected
intravenously with MC-38GFP and lungs analyzed 6 h later (MC-38
tumor +6 h i.v.); *=p<0.05 by ANOVA. b Mice bearing subcuta-
neous MC-38 tumors for 14 days were intravenously injected with
MC-38GFP cells and expression of E-selectin in the vicinity of
metastasizing tumor cells followed over time. Semiquantitative
analysis of E-selectin detection by metastatic MC-38GFP cells was
evaluated by Imaris software (p<0.001 by ANOVA). c Lungs of
mice carrying subcutaneous 3LL tumors that spontaneously metas-
tasize to the lungs were analyzed for E-selectin expression over time
and compared to lungs from healthy, tumor-naïve mice (no tumor).
Mice bearing 3LL tumors for 17 days (3LL tumor 17 D), but without
detectable metastasis, showed no significant difference compared to
tumor-naïve controls. However, E-selectin expression in the micro-
environment of metastasizing 3LL tumor cells was induced beyond
21 days (3LL tumor 21 D) and significantly increased at 24 days
(3LL tumor 24 D). **=p<0.01, by ANOVA
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to the upregulation of E-selectin [33]. Inhibition of E-
selectin expression by antisense oligonucleotides or by
function-blocking anti-E-selectin antibody attenuated ex-
perimental liver metastasis of tumor cells injected in the
spleen of a mouse [31, 41]. Our results indicate that E-
selectin expression does not directly promote metastatic
colonization of the lungs, but rather reflects the inflamma-
tory activation of endothelial cells. Thus, E-selectin may
contribute to initiation of metastasis in certain tissues, like
liver, while having a limited role in lungs. In another set of
studies, E-selectin was shown to contribute to transendo-
thelial migration of tumor cells in vitro [42, 43]. Tumor cell
extravasation is considered to be an important step during
lung colonization [10]. In the absence of E-selectin, we
observed no reduction of metastasis indicating that E-
selectin expression is unlikely to facilitate tumor cell
extravasation during lung colonization.
The role of E-selectin expression by the initial micro-
vascular arrest of metastatic tumor cells was studied in vitro
and in vivo [40, 44–46]. Conversely, our results show that
E-selectin is not present in the pulmonary microvasculature
during the initial arrest of metastatic tumor cells. Moreover,
E-selectin was not detected in the microenvironment of
metastatic tumor cells during the first 3 h after the arrest in
the microvasculature in mice with primary tumors (Fig. 3).
The contribution of E-selectin to metastasis was studied in a
cytokine-induced experimental lung metastasis model [40].
Treatment of human colorectal tumor cells, carrying E-
selectin ligands, with a soluble E-selectin prior to the
intravenous injection led to a reduction of metastasis in IL-
1 treated mice. However, the induced E-selectin expression
by a high cytokine dose unlikely reflects the natural process
of metastatic lung colonization. In another study, a peptide
mimic of E-selectin ligands was shown to reduce experi-
mental lung metastasis [46]. Yet, the peptide was not
specific only for E-selectin, but also bound to L- and P-
selectin [46]. Here we provide evidence that L- and P-
selectin contribute to the colonization of lungs (Fig. 6) and
both mediate initial steps of metastasis [19, 21, 23, 39].
P-selectin is known to mediate the interaction of tumor cells
with platelets, thereby enhancing experimental lung coloniza-
tion [24]. Platelets are important enhancers of hematogenous
dissemination, intravascular tumor cell survival and tissue
colonization [14, 17, 18, 24, 47–49]. Here, we show that P-
selectin is detected during the first hours of metastatic lung
colonization that is in agreement with the previously
observed P-selectin dependent accumulation of platelets [21,
24]. This finding indicates that P-selectin-mediated interac-
tions primarily affect metastasis during the initiation of tissue
colonization. Heparin was shown to inhibit P- and L-selectin
and its application at the time of tumor cell injection strongly
attenuated metastasis [24, 25, 50]. Recently, we provided
evidence that P-selectin-mediated interactions between tumor
cells and platelets facilitate the inflammatory activation of
microvascular endothelial cells and the formation of a
permissive metastatic microenvironment [23].
Fig. 4 P-selectin expression in
the vicinity of tumor cells me-
tastasizing to the lungs. C57Bl6
mice were intravenously
injected with MC-38GFP cells
and lungs analyzed for the
P-selectin expression at indicat-
ed time points. a Representative
images of P-selectin (red)
detected in the metastatic
microenvironment of tumor cells
(green). Nuclei were stained
with DAPI (blue). Bar=20 µm.
b A relative quantification of
P-selectin presence around
metastatic MC-38GFP cells was
performed by Imaris software.
P-selectin detection was signifi-
cantly elevated at 30 min and
3 h after tumor cell injection
(30 min, p<0.001; 3 h,
p<0.05 by ANOVA)
102 H. Läubli, L. Borsig
Temporal blockage of L-selectin function caused an
attenuation of experimental metastasis to similar levels as
observed in L-selectin deficient mice, suggesting a critical
contribution of leukocytes during the initiation phase of
metastasis [21]. Furthermore, the absence of L-selectin
resulted in a decreased recruitment of myeloid cells to
metastasizing tumor cells [21]. In this study, we show that
L-selectin accumulation in the metastatic microenvironment
timely correlated with the recruitment of leukocytes.
Myeloid cells were shown to support tumor progression
and metastatic colonization in different mouse models [23,
34, 36, 51]. Thus, it is conceivable that L-selectin
participates in the recruitment of myeloid cells to metastatic
cells and thereby facilitates the permissive metastatic
microenvironment.
Presented data together with several recent studies
support the hypothesis that the microenvironment of
metastatic tumor cells undergoes an inflammatory
activation during lung colonization [21–23, 34, 52].
Activation of endothelial cells results in an upregulation
of cell adhesion molecules, E-selectin and VCAM-1 and
secretion of chemokines including CCL5 that facilitates
the recruitment of monocytes [23]. Furthermore this
endothelial activation is dependent on P-selectin mediated
interactions of platelets with tumor cells. Finally, the
recruitment of myeloid cells and monocytes to the
metastatic sites is dependent on L-selectin mediated
interactions that further contribute to the formation of a
metastatic niche [21, 23]. From the timely sequence of
events during metastatic initiation, P-selectin seems to
facilitate initial steps, while L-selectin and possibly E-
selectin participate in the subsequent steps of metastasis
progression. Thus, a selective targeting of selectins
represents a valid therapeutic approach for inhibition of
hematogenous metastasis.
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Fig. 5 L-selectin detection in the pulmonary microenvironment of
metastatic tumor cells. C57Bl6 mice were intravenously injected with
MC-38GFP cells and lungs analyzed for the presence of L-selectin at
indicated time points. a L-selectin positive cells were quantified in the
microenvironment of hematogenously metastasizing tumor cells. The
association of L-selectin positive cells with MC-38GFP cells during
early lung colonization was analyzed. Statistically significant increase
in expression at 12, 18 and 24 h when compared to earlier timer points
was observed (12 h, p<0.05, 18 and 24 h p<0.001, determined by
ANOVA). b Representative images of L-selectin positive cells (red) in
the pulmonary microenvironment of metastasizing MC38-GFP cells
(green) 18 and 24 h after intravenous injection. Nuclei were stained
with DAPI (blue). Bar=20 μm. c Relative quantification of L-selectin
staining around metastatic MC-38GFP cells during the first 48 h of
lung colonization was performed by Imaris software. L-selectin
detection was significantly increased at 18 and 24 h after tumor cell
injection (p<0.001 by ANOVA)
Fig. 6 Experimental metastasis in selectin deficient mice. LS180 cells
were intravenously injected into RAG2 deficient mice (wt), P-selectin
(Psel-/-), L-selectin (Lsel-/-) or E-selectin (Esel-/-) deficient mice in a
Rag2 deficient background, respectively. After 5 weeks, lungs were
harvested and metastasis was assessed by quantification of human
ALU sequences. ANOVA with a Bonferroni post-hoc test was
performed for determination of a statistical significance
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